ENDRA Life Sciences Inc. — Director's Dealing 2022

Aug 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2022-08-22

Reporting Person: Tokman Alexander Y (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-22	Common Stock	P	20000	$0.26	Acquired	152857	Direct